Evgen Pharma plc (EVG) Ordinary 0.25p
1.13p
(8.11%)
- Add to watchlist
- Create an alert
- This stock can be held in a
1.13p
(8.11%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA,
SIPP or
Fund and Share Account
1.13p
(8.11%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA,
SIPP or
Fund and Share Account
14.00p
15.18p
28.50p
£19.90 million
13.88p
13.86p
13.50p
n/a
0.00p (0.00%) Previous:
0.00p
797,085
n/a
5,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/03/2019 | 31/03/2018 |
|---|---|---|
| Revenue (£m) | n/a | n/a |
| Profit before tax (£m) | (3.12) | (3.03) |
| Adjusted EPS (p): | (2.74) | (3.28) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
-
Strong Sell
(0 of 1) -
Sell
(0 of 1) -
Neutral
(1 of 1) -
Buy
(0 of 1) -
Strong Buy
(0 of 1)
This is not a recommendation, it represents the consensus view of a basket of brokers. If fewer than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.
Full broker forecasts-
Evgen Pharma upbeat on latest news from SFX-01 studies
23 September 2019 10:03
-
Evgen Pharma completes patient study visits in 'SAS' phase 2 trial
28 August 2019 14:30
-
Evgen Pharma gets further protection for 'SFX-01' in Europe
7 August 2019 13:52
-
ESMO presentation of Phase II STEM clinical data
30 September 2019 07:00
-
Update on extended-use phase of STEM trial
23 September 2019 07:00
-
Agreement for supply of SFX-01 for autism trial
5 September 2019 07:00
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA,
SIPP or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.